Trump’s trumpet: The challenges of being over-reliant on foreign funding
DOI:
https://doi.org/10.7196/Keywords:
HIV fundingAbstract
-
References
1. Duenas N. Trump’s push to shut down USAID shows how international development is also about strategic interests. The Conversation, 6 February 2025. https://theconversation.com/trumps-push- to-shut-down-usaid-shows-how-international-development-is-also-about-strategic-interests-249118 (accessed 24 February 2025).
2. Malan M. BREAKING: Trump orders USAID-funded HIV organisations in SA to shut down.
https://bhekisisa.org/health-news-south-africa/2025-02-27-breaking-trump-orders-usaid-funded-
hiv-organisations-in-sa-to-shut-down/ (accessed 27 February 2025).
3. NtusiN.USaidcutsareanopportunitytoreimagineglobalhealth.Theglobalsouthshouldbecome
self-reliant by investing in health. Nature, 10 February 2025. https://www.nature.com/articles/
d41591-025-00009-9 (accessed 24 February 2025).
4. Malan M, Booysen D, Mdzeke Y. Weaponising aid: The cruel ways of #Trump2025. Bhekisisa, 30
January 2025. https://bhekisisa.org/multimedia/podcasts/2025-01-30-listen-weaponising-aid-the-
cruel-ways-of-trump2025/ (accessed 24 February 2025).
5. Director General, National Department of Health. Provision of uninterrupted HIV services across
all health facilities. Bhekisisa, 2025. https://bhekisisa.org/wp-content/uploads/2025/02/Circular-on-
the-provision-of-uniterrupted-HIV-and-AIDS-Services-1.pdf (accessed 24 February 2025).
6. Reuters. Trump’s aid cuts stop South African HIV vaccine trials in their tracks. Polity, 18 February 2025. https://www.polity.org.za/article/trumps-aid-cuts-stop-south-african-hiv-vaccine-trials-in-
their-tracks-2025-02-18 (accessed 24 February 2025).
7. JUTA Medical Brief. Trump’s aid cuts halt crucial SA-led HIV vaccine trials. Medical Brief,
19 February 2025. https://www.medicalbrief.co.za/trumps-aid-cuts-halt-crucial-sa-led-hiv-vaccine- trials/ (accessed 24 February 2025).
Downloads
Published
Issue
Section
License
Copyright (c) 2025 A Dhai
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Licensing Information
The SAMJ is published under an Attribution-Non Commercial International Creative Commons Attribution (CC-BY-NC 4.0) License. Under this license, authors agree to make articles available to users, without permission or fees, for any lawful, non-commercial purpose. Users may read, copy, or re-use published content as long as the author and original place of publication are properly cited.
Exceptions to this license model is allowed for UKRI and research funded by organisations requiring that research be published open-access without embargo, under a CC-BY licence. As per the journals archiving policy, authors are permitted to self-archive the author-accepted manuscript (AAM) in a repository.
Publishing Rights
Authors grant the Publisher the exclusive right to publish, display, reproduce and/or distribute the Work in print and electronic format and in any medium known or hereafter developed, including for commercial use. The Author also agrees that the Publisher may retain in print or electronic format more than one copy of the Work for the purpose of preservation, security and back-up.
